Your clinician will answer any questions you have and work with you to provide the recommendations you need to hit your goals
In this guide, we will cover this along with the science, safety, expected outcomes, and more
Discuss your health concerns, options for weight loss, dietary supplements and exercise recommendations
Millions of people are turning to GLP-1s for weight loss, but many are surprised to learn that the medication alone isn't enough
The Phase 2/3 LIFT-AD trial (NCT04488419), evaluating once-daily subcutaneous fosgonimeton 40 mg versus placebo in 312 participants with mild-to-moderate Alzheimers disease over 26 weeks, failed its primary endpoint (Global Statistical Test composite of ADAS-Cog11 and ADCS-ADL23) and its key secondary endpoints when results were announced in September 2024
Both Mounjaro and Wegovy have different mechanisms of action, dosing schedules, and potential side effects